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Dermal angiopathy in hemodialysis patients: The effect of time. We
studied skin biopsies from 14 patients after 6 months to 18 years on
hemodialysis (HD) to discern any effect of duration of treatment on skin
and dermal capillaries. Patients selected for biopsy were without evidence
of other diseases known to affect vasculature such as diabetes mellitus.
Pathological changes compared with duration of HD were: capillary wall
thickening, endothelial proliferation and new capillary formation, lipid
content, and epidermal atrophy. Severity of morphologic changes were
graded from 0 to 4+ by a pathologist who had no knowledge of HD
duration. The earliest change observed was reduplication of the capillary
basement membrane. Narrowing of capillary lumina due to endothelial
cell proliferation and new capillary formation were noted after five years
of HD; lipid droplets were noted in capillaries by five years; and epidermal
atrophy by 10 years. Progressive severity of each finding was associated
with length of time on HD. Neither amyloid nor Ca deposits were
observed in any specimens. By clinical observation, easy bruisability and
increased skin fragility were worse the longer the patient was on HD.
Capillary occlusion inducing tissue ischemia could be a cause of the
atrophic skin changes noted. However, no patient manifested dermal
necrosis. While pathogenesis of the capillary changes in uremic skin is
unknown, the changes have been shown to stabilize following successful
kidney transplantation.
The skin of HD patients, particularly in long duration subjects,
is easily torn and bruised even with mild trauma. The pathogen-
esis for this increased fragility of skin and capillaries is unclear.
Damage to capillaries has been found in both skin and muscles of
uremic and dialysis patients [1—3]. In these reports, evidence
suggests that microangiopathy worsens with duration of dialysis
therapy but no correlation with specific dermal pathology or
symptoms has been established. Following renal transplantation,
capillary changes improve [1] or stabilize [31. To explore the
genesis of skin abnormalities in uremia, we took skin biopsies
from 14 patients who had been on HD for 6 months to 18 years.
We assessed the association of duration of HD on the epidermis
and its capillaries.
Methods
Patients selected for skin biopsy were free of diseases known to
affect skin or capillaries other than persistence of uremia. Eleven
were men and three women, seven black and seven white. They
ranged in age from 30 to 55 years. No patient had a history of
diabetes and blood pressure was satisfactorily controlled in all at
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time of biopsy. At the time this study was performed, all patients
had a treatment prescription resulting in an average urea reduc-
tion ratio (URR) of about 55 to 60%.
Skin was biopsied with a punch biopsy (3.5 mm) on the smooth,
non-hairy skin of the forearm without an active HD blood access.
Samples were fixed in 3% glutaraldehyde with phosphate buffer
and then placed in osmium tetroxide. Tissue was dehydrated in
graded alcohol and embedded in epon. Each biopsy was divided
into an average of 10 pieces for study. One micron thick sections
were stained with toluidine blue for light microscopic (LM)
studies. For electron microscopy (EM), these sections were cut in
600 angstrom slices by an LKB Ultratome III. These sections were
then stained with uranil acetate and lead citrate.
Skin capillary changes were graded according to: reduplicated
basement membrane (BM) thickness and endothelial prolifera-
tion, number of capillaries per low powered field, and lipid
content. The evaluating pathologist (1(F) lacked knowledge of the
clinical condition of the patients and their time on HD. Grading
scales for capillary wall thickness (ratio), neoproliferation (#/lpf),
lipid content, and epidermal atrophy (cells) are given in Table 1.
Capillary wall thickness was measured by a ratio of:
lumen + endothelium + BM
lumen + endothelium
In normal capillaries the BM is so thin that the ratio (Grade 0)
is 1:1. The usual number of capillaries per lpf (Grade 0) is 2 or
less. Lipid content was measure by a planimeter, an instrument for
measuring the area of a plane figure by tracing its boundary line.
In nonuremic patients of similar age to our subjects and without
evidence of atherosclerotic disease, the expected lipid content
would be 0. Epidermal thickness included rete ridges and the
spinous layer. Normal epidermis (Grade 0) is 8 to 10 cells thick.
Results
The severity of skin microangiopathy and epidermal atrophy
correlated with duration of dialysis (Table 2). Pathologic changes
were not related to patient age, per Se. Figure 1, an LM view of
normal skin, can be contrasted with Figure 2 which shows severe
capillary wall thickening, neoproliferation and epidermal atrophy
after 15 years of HD. In a normal capillary the BM is barely
visible. In long-term HD patients, the basal lamina increases in
thickness to become more than the width of the capillary lumen.
This change is seen in a 10 year HD patient in Figure 3. Basement
membrane reduplication is present when the capillary lumen
begins to narrow due to endothelial cell swelling and proliferation
(Fig. 4). Eventually the lumen becomes a narrow slit restricting
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Table 1. Grading scales
Capillary .Epidermal
atrophyThickness Proliferation
Grade 1+ 1—1.25:1 2—4 6—7
Grade 2+ 1.25—1.5:1 4—6 5—6
Grade 3+ 1.5—1.75:1 6—8 < 5
Grade4+ >2 >8
Skin capillary changes were graded according to:
reduplicated membrane thickness;
proliferation of capillaries # per lpf; and
lipid content. Normal capillary BM thickness (Grade 0):
lumen + endothelium + BM
lumen + endothelium
—
Normal capillary # (Grade 0) = 2 per lpf.
Normal amount of lipid as measured by planimetry 0.
Epidermal atrophy including rete ridges and spinous layer (Grade 0)
= 8—10 cells thick.
blood flow (Fig. 5). Capillary thickness can be discerned at the
start of HD but luminal narrowing isn't noted until about five
years of HD, with occlusion noted after 10 years. Accumulation of
lipid droplets (Fig. 5) and epidermal atrophy appear with narrow-
ing of the capillary lumen and progress concurrently. Lipid
droplets seen within a lamelatted BM are ultrastructurally similar
to lipofuscin granules. Neither amyloid fibrils nor calcium deposits
were observed in any of the skin biopsies.








1 6m 1+ 0 0 0
2 lOm 1+ 0 0 0
3 18m 1-4- 0 0 0
4 2y 1+ 0 0 0
5 4y 2+ 1+ 0 0
6 4y 2+ 1+ 0 0
7 5y 2+ 1+ 0 0
8 5y 2+ 1+ 1+ 09 by 3+ 2+ 2+ 2+
10 by 3+ 2+ 3+ 2+
11 15y 3+ 3+ 3+ 2+
12 15y 4+ 4+ 4+ 2+
13 17y 4+ 3+ 3+ 3+
14 l8y 4+ 4+ 4+ 3+
Abbreviations are: m, months; y, years.
Fig. 1. Normal skin (X320).
Discussion
An association between skin abnormalities and kidney failure
was noted in Richard Bright's 1827 description that "the altered
action of the kidney is the result of the various hurtful causes
mediating it through the medium of the stomach and the skin
[41. Sir Dyce Duckworth felt that the skin irritation he noted in a
uremic patient was "due to toxic matters resulting from disor-
dered renal metabolism" [5]. The latter view is held today when
Fig. 3. Dem,aI capillariesshowing wall thickening and endothelial proilfer-
1 1' I IA-I I .1
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Fig. 2. Severe capillaty wall thickness, proliferation and derinal atrophy in
long term (15 years) hemodialysis patient (><75).
the causes of uremic xerosis, pruritus, stomatitis and purpura are
considered. As a result of early diagnosis and dialysis intervention,
complications of uremia such as uremic frost, oral and gastroin-
testinal ulcerations, and abnormal bleeding due to impaired
platelet function are seldom seen in developed countries.
Today, dermatologic manifestations of chronic renal failure
seen in HD patients include: hyperpigmentation, xerosis and
impaired sweating (hypohidrosis), and pruritus, as well as easy
bruising and increased skin fragility. Hyperpigmentation results
from skin retention of urochrome pigments such as lipochromes
and carotenoids which is lessened by dialysis [6]. Additionally, a
brown diffuse coloration, more evident in sun exposed areas, is
thought due to /3-melanocyte stimulating hormone which is not
excreted in uremia and is poorly dialyzable [7]. Dry skin and
decreased sweating may have a common etiology which is un-
known. Pruritus, the most troubling of skin problems in uremic
and dialysis patients, is attributed to a number of causes, some of
which respond to specific treatments 8].
We have noted bruising and tearing of the skin with light
trauma in long-term HD patients. Although bleeding times, a sign
of platelet dysfunction, are prolonged in HD patients, neither
thrombocytopenia nor abnormal bleeding from other sites is
common. Epidermal and dermal atrophy were described in ure-
mic patients over 60 years ago [9]. Other skin changes reported in
uremic patients of the predialysis era include pericapillary prolif-
ig. 3. Derinal capillaries howing wall thi ni  nd endothelial r li
ation. Graded 3+ in 10 year hemodialysis patient (X280).
eration, increased numbers of capillaries with swollen endothelial
cells containing pyknotic nuclei, and degeneration of sweat and
sebaceous glands. These changes were noted to have progressed
over weeks. Similar abnormalities have been found in both skin
and muscle capillaries of HD patients [1—3]. That the capillary
damage stabilizes or improves after kidney transplantation sug-
gests an etiologic contribution of uremic factors, dialysis exposure
or both.
Gilchrest observed skin capillary damage in uremia similar to
that found in a number of inflammatory dermatoses such as
contact allergy and atopic eczema. These occurred more severely
in cutaneous necrotizing vasculitis and skin allograft rejection [1].
A common thread in these disorders could be immune complex
deposition or proliferation of pericapillary mast cells, events said
to take place in uremia and dialysis 2, 10]. In renal failure
patients, however, capillary changes are noted in normal skin,
without microscopic evidence of immune complexes or mast cells.
The same holds true for the patients we studied.
The microangiopathy of diabetes mellitus is independent of
macrovascular disease and Consists of markedly thickened capil-
lary walls, widening of the BM and proliferation of endothelial
cells, all changes seen in uremia and HD. Diabetic microangiopa-
thy, most apparent in the kidney and eyes, also affects other
tissues, including normal appearing skin and muscles early in the
disease [11, 12]. Brenner hypothesized that renal and retinal
capillary damage in diabetes is due to precapillary vasodilatation
leading to elevation in capillary pressures and flows [13]. It is
;_-_ .i
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Fig. 4. A capillaty after 18 months on dialysis.
There is proliferation of endothelial cells
(arrow). The BM is layered and slightly
thickened (X 12800).
postulated that these hemodynamic events then promote endo-
thelial proliferation, with consequent thickening of BMs and
luminal narrowing in other capillary beds as well [141. Anemic
uremie and dialysis patients are in a hyperdynamic state, with
increased tissue blood flow at least early in the course of renal
failure. However, neither renal nor retinal lesions similar to those
of diabetes are seen in non-diabetic uremic patients. The hem at-
ocrit and circulation are restored toward normal after replace-
ment with recombinant erythropoietin or renal tissue by trans-
plantation. This benefit could account for amelioration of the
capillary damage after kidney transplantation. Our study was
completed before the advent of recombinant erythropoietin so
that we cannot answer the question as to whether restoration of a
more normal hematocrit can forestall cutaneous microangiopathy
in uremic or HD patients.
Both diabetic patients and those with chronic renal failure from
any cause have high concentrations of advanced glycosylation
end-products (AGEs) in their blood [15—17]. Pathogenesis of the
increased levels of AGEs in normoglycemic HD patients is
unclear. AGEs are thought to play a role in diabetic nephropathy
[18]. Furthermore, an effect of AGEs on capillary wall thickening
in diabetes is suggested by evidence that the width of skeletal
muscle capillary basement membrane is reduced [19] or can be
prevented [20] by good control of blood glucose. Whatever causes
high levels of AGEs in long-term HD patients could contribute to
capillary wall thickening as well.
Uremic serum contains factors that stimulate proliferation in
cultured human arterial smooth muscle cells and dermal fibro-
blasts [211. Polyamines and homocysteine, both elevated in uremic
serum, are mitogenic for smooth muscle cells [22—241. Platelet-
derived growth factor (PGDF) is the main source of mitogenic
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Fig. 5. A capillaty from a patient 17 years on
hemodialysis. The lumen is virtually obliterated
and BM thickness is far advanced. Electron
dense material deposited in BM is
morphologically identical to lipofuscin
(>< 12800).
Dialysis membranes of low biocompatibility, such as cuprophane
in particular, can increase plasma mitogenic activity threefold
[26]. Whether this increase of mitogenic activity is due to en-
hanced release of PDGF or other factors is to be determined.
Effects of such substances on capillaries similar to that of arteries
and arterioles is not clear.
Our findings in skin in HD patients strengthen the impression
that these abnormalities progress and worsen with length of time
on HD, even though the skin appears superficially normal. Most
prominent on LM is the greatly increased number of occluded
capillaries with marked thickening of BM-like material, as well as
progressive atrophy of the epidermis. Also noted, however, are
new capillaries, which probably prevent dermal necrosis due to
tissue ischemia, as might be expected from the severity of the
capillary occlusion observed in EM. This new capillary formation
may account for the regression of skin perturbations after trans-
plantation [11. It is unlikely that such severe damage to capillaries
would be reversible.
The lipid granules seen in the capillaries on EM are ultrastruc-
turally similar to lipofuscin granules said to represent undisposed
lipid material. For years lipofuscin has been an incidental finding
in postmortem specimens associated with aging. Recently, how-
ever, the significance of lipofuscin has grown with the recognition
of oxidative stress as a cause of lipofuscin formation [27].
In chronic renal failure patients, elevated plasma levels of
soluble lipofuscins are found [28]. HD patients have oxidative
stresses when they are exposed to bioincompatible dialyzer mem-
branes [29—31]. Many long-term dialysis patients appear to have
aged prematurely possibly as a consequence of increased oxidative
activity. In our study, the longest duration HD patients with the
most capillary lipid deposits were not necessarily the oldest.
In conclusion, skin capillary and dermal changes including
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capillary wall thickening, endothelial cell proliferation, new cap-
illary formation, lipid deposition, and epidermal atrophy correlate
with length of time on hemodialysis. At the same time, greater
skin fragility and ease of bruising were observed in the longest-
term dialysis patients, while skin necrosis was not seen in any.
Notable deposits of calcium or amyloid were absent. The cause(s)
of these dermal changes is (are) unknown, but capillary flow
alterations and/or exposure to toxic substances or oxidizing events
could be important contributing factors.
Reprint requests to A. Peter Lundin, M.D., SUNY Health Science Center
at Brooklyn, 450 Clarkson Aye, Box 52, Brooklyn, New York 17203, USA.
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